Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Gordon Research Conference on Synaptic Dysfunction and Neurodegeneration
Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.
Flupirtine
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report.
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
Berlex continues legal challenge to FDA over MS drug.
Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients.
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro.
A gender gap in autoimmunity.
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial.
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro.
Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells.
American Society for Neurochemistry Annual Meeting
Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication.
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.
Merck: Regulatory Update on Cladribine Tablets
Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
NICE recommends new treatment option for multiple sclerosis (Dimethyl fumarate)
β-Amyloid: Enemy or Remedy?
Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?
Teriflunomide for multiple sclerosis.

Pages